Search

everythinglearnresearchcommunity

for

Search:↓

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Genetic testing is crucial for diagnosing and treating acrodermatitis enteropathica effectively.

These gene variations are not linked to alopecia areata in Egyptians.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

SQSTM1 is linked to increased risk of alopecia areata.

Specific RNA patterns are linked to alopecia areata.

XEDAR deficiency prevents muscle degeneration in EDA-A2 transgenic mice.

Researchers found a new mutation in the HR gene causing hair loss and skin bumps in a Pakistani family.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Impaired ABCA5 activity disrupts cholesterol balance in hair follicle cells, affecting hair growth.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Researchers found four genes that could help diagnose severe alopecia areata early.

Modulating the BTNL2 pathway can prevent hair loss in mice.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

The LMNA mutation affects skin structure even in asymptomatic carriers.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

CCCA may be caused by both hair traction and an immune response.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Controlling Tslp can improve health in AEC syndrome patients.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

Specific mutations in a receptor cause facial abnormalities and hair loss.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Alopecia areata affects about 2% of people and can impact any hair area.